Mrs. Rekha Devi, age 45, had an HbA1c test which showed a level of 11.1%, indicating diabetes. Her fasting blood glucose was also high at 262 mg/dL. HbA1c levels between 6.5-7% indicate need for treatment to control blood sugar. Both results suggest the patient has poorly controlled diabetes and needs to work with her doctor to improve blood sugar management through medication, diet, and lifestyle changes.
Mrs. Rekha Devi, age 45, had an HbA1c test which showed a level of 11.1%, indicating diabetes. Her fasting blood glucose was also high at 262 mg/dL. HbA1c levels between 6.5-7% indicate need for treatment to control blood sugar. Both results suggest the patient has poorly controlled diabetes and needs to work with her doctor to improve blood sugar management through medication, diet, and lifestyle changes.
Mrs. Rekha Devi, age 45, had an HbA1c test which showed a level of 11.1%, indicating diabetes. Her fasting blood glucose was also high at 262 mg/dL. HbA1c levels between 6.5-7% indicate need for treatment to control blood sugar. Both results suggest the patient has poorly controlled diabetes and needs to work with her doctor to improve blood sugar management through medication, diet, and lifestyle changes.
Mrs. Rekha Devi, age 45, had an HbA1c test which showed a level of 11.1%, indicating diabetes. Her fasting blood glucose was also high at 262 mg/dL. HbA1c levels between 6.5-7% indicate need for treatment to control blood sugar. Both results suggest the patient has poorly controlled diabetes and needs to work with her doctor to improve blood sugar management through medication, diet, and lifestyle changes.
Name : Mrs. REKHA DEVI Collected : 20/1/2020 6:57:00PM
Received : 20/1/2020 7:06:20PM Lab No. : 270823716 Age: 45 Years Gender: Female Reported : 21/1/2020 3:21:17PM A/c Status : P Ref By : SELF Report Status : Final
Test Name Results Units Bio. Ref. Interval
HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD (HPLC)
HbA1c 11.1 % Estimated average glucose (eAG) 272 mg/dL
Result Rechecked, Please Correlate Clinically.
Note:- Urgent repeat advise in case there is no clinical correlation.
Interpretation ------------------------------------------------------------------------------- | As per American Diabetes Association (ADA) | |-------------------------------------------------------------------------------| | Reference Group | HbA1c in % | |-------------------------------|-----------------------------------------------| | Non diabetic adults >=18 years| 4.0 - 5.6 | |-------------------------------|-----------------------------------------------| | At risk (Prediabetes) | 5.7 - 6.4 | |-------------------------------|-----------------------------------------------| | Diagnosing Diabetes | >= 6.5 | |-------------------------------|-----------------------------------------------| | Therapeutic goals for glycemic| . Goal of therapy: < 7.0 | | control | . Action suggested: > 8.0 | -------------------------------------------------------------------------------
Note 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled 2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate 3. Any condition that shortens erythrocyte survival such as sickle cell disease, pregnancy (second and third trimesters), hemodialysis, recent blood loss or transfusion, or erythropoietin will falsely lower HbA1c results regardless of the assay method 4. In patients with HbA1c level between 7-8%, Glycemark (1,5 Anhydroglucitol) test may be done to identify those with more frequent and extreme hyperglycemic excursions
Name : Mrs. REKHA DEVI Collected : 20/1/2020 6:57:00PM
Received : 20/1/2020 7:06:20PM Lab No. : 270823716 Age: 45 Years Gender: Female Reported : 21/1/2020 3:21:17PM A/c Status : P Ref By : SELF Report Status : Final
Test Name Results Units Bio. Ref. Interval
Comments HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary glucose determinations. This single test can be used both for diagnosing & monitoring diabetes. ADA recommends measurement of HbA1c 3-4 times per year in Type 1 diabetes and poorly controlled Type 2 diabetes patients. In well controlled Type 2 diabetes patients, the test can be performed twice a year.
Name : Mrs. REKHA DEVI Collected : 20/1/2020 6:57:00PM
Received : 20/1/2020 7:06:20PM Lab No. : 270823716 Age: 45 Years Gender: Female Reported : 21/1/2020 3:21:17PM A/c Status : P Ref By : SELF Report Status : Final
Dr Anita MD, Pathology Chief of Laboratory Dr Lal PathLabs Ltd
-------------------------------End of report --------------------------------
IMPORTANT INSTRUCTIONS
*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory . *Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact customer care Tel No. +91-11-39885050 for all queries related to test results. (#) Sample drawn from outside source.
